僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Brontictuzumab （OMP 52M51） is a monoclonal antibody （MAb） that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma